UBS Downgrades U.S. Stock Market
UBS has downgraded its outlook for U.S. stocks, warning that key supports for the market are weakening. The firm points to the diminishing impact of corporate stock buybacks and significant "asymmetric structural downside risks" to the U.S. dollar. UBS is advising clients to brace for volatility and diversify away from U.S.-centric portfolios.
The downgrade, led by UBS's Head of Global Equity Strategy Andrew Garthwaite, shifted the firm's official outlook on U.S. stocks from "Overweight" to "Benchmark," a neutral weighting. This move was part of a broader strategic retreat, following a downgrade of the Technology and Communication Services sectors to "Neutral" earlier in February 2026. A primary catalyst for the decision was a surprise 0.5% month-over-month increase in the January Producer Price Index (PPI), which significantly exceeded economists' expectations. The Core PPI, which excludes volatile food and energy prices, saw its largest monthly surge in services since mid-2025, challenging the prevailing "soft landing" economic narrative. Valuations for U.S. stocks are a key point of concern, with the sector-adjusted price-to-earnings ratio trading 35% above that of international peers. This premium is becoming harder to justify as the U.S. "buyback yield" has fallen to parity with the rest of the world, removing a previously significant driver of domestic earnings-per-share growth. The bank's foreign exchange team anticipates a structural decline for the U.S. dollar, forecasting a EUR/USD exchange rate of 1.22. Historically, a 10% fall in the trade-weighted dollar index has resulted in U.S. stocks underperforming global markets by approximately 4%. This shift in sentiment is reflected in year-to-date market performance. While the S&P 500 has remained relatively flat, the MSCI World ex-USA Index has gained about 8%, and Japan's Nikkei 225 has surged by roughly 17%. UBS also highlighted an "uncertainty premium" fueled by shifting White House policies. The firm cited frequent policy adjustments concerning tariffs, proposed caps on credit card interest rates, and reviews of drug pricing as factors that challenge the stability of corporate earnings expectations. In response, capital has already begun flowing to overseas markets. ETF flow data shows a significant portion of capital moving into regions outside the U.S., and UBS noted that some North American institutional clients are shifting new allocations abroad. The bank has maintained its "overweight" position on emerging market equities.
